LONDON (ShareCast) - (Sharecast News) - Software firm Craneware said on Monday that both revenue and earnings had grown in the year ended 30 June, reflecting its operational focus and strategic position "at the heart" of the US healthcare market.
Craneware said revenues were up 9% year-on-year at $205.7m, with annual recurring revenues 7% higher at $184m and an increase in associated net revenue retention to 107%.

Adjusted underlying earnings were 12% higher at $65.3m, while statutory pre-tax profits shot up 52% to $24m, benefitting from a reduction in finance costs driven by Craneware's treasury management policy. Adjusted basic earnings per share increased 22.5% to $1.16 each.

Craneware also noted that total cash and cash equivalents strengthened to $55.9m in the year, and said total bank debt was further reduced to $27.7m.

As a result, Craneware upped its dividend for the year by 10%, with a proposed final dividend of 18.5p per share, resulting in a total dividend of 32.0p per share.

Looking ahead, Craneware said trading in the first months of the new year had "started well", which, alongside the FY25 revenue growth, provided it with confidence in "continued growth acceleration" in FY26.

Chief executive Keith Nelson said: "Trading in the current year has started well, and with high customer retention rates, market-leading offerings, specialist healthcare expertise and a significant proprietary data set, we have strong foundation on which to build.

"The growth in both ARR and NRR in the year demonstrates the strength of our Annuity SaaS business model, backed by multi-year contracts, providing a basis for growth acceleration in the year to come, and we look to the future with confidence."

As of 0810 BST, Craneware shares were down 1.32% at 2,240p.





Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE